On behalf of the American Association for Cancer Research (AACR) and the Korean Cancer Association (KCA), we have the great pleasure to invite you to attend the first AACR-KCA Joint Conference on Precision Medicine in Solid Tumors, which will be held from November 15-17, 2018, in Seoul, Korea.
The conference will feature a keynote lecture by Waun Ki Hong, M.D., F.A.C.P., D.M.Sc (Hon), Division Head and Professor at The University of Texas MD Anderson Cancer Center, an American Cancer Society Professor, and a Samsung Distinguished University Chair in Cancer Medicine. A national and international leader in medical oncology, Dr. Hong is a foremost authority on the treatment and prevention of head and neck cancer and lung cancer. His expertise spans more than 36 years of unprecedented advances in translational and clinical cancer research.
The program will also feature prominent international and local experts on the latest research covering the entire cancer research spectrum, including: Cancer Genomics, Precision Diagnostics: NGS-based Cancer Panels, Liquid Biopsy, Novel Technologies, Immunology: Biomarkers and Therapies, Novel Targets, Epigenomics and Immunology: Technologies and Innovations. This interactive three-day program will also include an educational session on Genome-Driven Clinical Trials and two poster sessions for attendees to discuss their latest research.
We invite you to join us at the Lotte Hotel Seoul for the 2018 AACR-KCA Joint Conference on Precision Medicine in Solid Tumors and look forward to receiving your abstract submissions and seeing you in Seoul in November. We are confident that you will find this to be an engaging and insightful meeting, and we hope that you will take full advantage of the opportunity to network with colleagues from around the world and forge collaborations that will bring us all closer to our unified mission to prevent and cure cancer.
Seoul National University Hospital
Charles L. Sawyers
Memorial Sloan Kettering Cancer Center